COVID-19: Caring for Patients and Communities
AHA’s The Value Initiative is providing new resources to support hospitals’ and health systems’ efforts to adopt team-based care for patients with an acute or chronic illness.
A Lancet study published Sept. 25 indicates that few in the U.S. adult population formed antibodies against SARS-CoV-2, at least during the virus’ first wave in this country.
More than 200,000 of our friends, family members, fellow citizens and front-line workers have succumbed to COVID-19 since March. To put that in context, that’s approximately the same as the population of Salt Lake City, Utah.
The fourth in the series featured Dr. Estes joined by Dr. David W. Zaas, CEO of MUSC Health - Charleston Division and Chief Clinical Officer for MUSC Health, to discuss COVID-19’s impact on health trends and services in South Carolina. This episode was recorded on September 24, 2020.
The Food and Drug Administration reissued its emergency use authorization for the Abbott ID NOW COVID-19 test to indicate that the product is intended for specimens collected “from individuals who are suspected of COVID-19 by their health care provider within the first seven days of the onset of…
Proactive COVID-19 testing of all long-term care staff and residents, who are usually at higher risk of contracting the virus, may help prevent potential outbreaks, according to a Centers for Disease Control and Prevention study.
The Food and Drug Administration approved a new drug application for propofol injectable emulsion, an intravenous general anesthetic and sedation drug in short supply.
In a sample of 598 hospitalized pregnant women with COVID-19, 55% had no symptoms on admission, according to a report released by the Centers for Disease Control and Prevention.
The National Institutes of Health awarded $12 million to non-profit research institution RTI International for outreach and engagement efforts in ethnic and racial minority communities that have been disproportionately affected by the COVID-19 pandemic.
The Department of Health and Human Services released its strategy for the public distribution of a COVID-19 vaccine. HHS said that it developed the strategy in coordination with the Department of Defense and the Centers for Disease Control and Prevention.